You have free access to this content

HIV Medicine

Cover image for Vol. 11 Issue 2

February 2010

Volume 11, Issue 2

Pages 95–160

  1. Original research

    1. Top of page
    2. Original research
    1. You have free access to this content
    2. You have free access to this content
      Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients (pages 104–113)

      P Cicconi, A Cozzi-Lepri, A Castagna, EM Trecarichi, A Antinori, F Gatti, G Cassola, L Sighinolfi, P Castelli, A D'Arminio Monforte and for the ICoNA Foundation Study Group

      Version of Record online: 1 SEP 2009 | DOI: 10.1111/j.1468-1293.2009.00750.x

    3. You have free access to this content
      Immunosuppression among HIV-1-positive patients attending for care: experience from two large HIV centres in the United Kingdom (pages 114–120)

      D Harte, O Dosekun, G Sethi, T Chadborn, A De Ruiter, A Copas, SG Edwards and RF Miller

      Version of Record online: 20 AUG 2009 | DOI: 10.1111/j.1468-1293.2009.00753.x

    4. You have free access to this content
    5. You have free access to this content
      Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort study (pages 130–136)

      N Obel, DK Farkas, G Kronborg, CS Larsen, G Pedersen, A Riis, C Pedersen, J Gerstoft and HT Sørensen

      Version of Record online: 13 AUG 2009 | DOI: 10.1111/j.1468-1293.2009.00751.x

    6. You have free access to this content
      Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trial (pages 137–142)

      J Ghosn, P Flandre, I Cohen-Codar, P-M Girard, M-L Chaix, F Raffi, P Dellamonica, P NgoVan, M Norton, J-F Delfraissy, for the MONARK and Study Group

      Version of Record online: 13 AUG 2009 | DOI: 10.1111/j.1468-1293.2009.00752.x

    7. You have free access to this content
      Towards a combined prognostic index for survival in HIV infection: the role of ‘non-HIV’ biomarkers (pages 143–151)

      AC Justice, KA McGinnis, M Skanderson, CC Chang, CL Gibert, MB Goetz, D Rimland, MC Rodriguez-Barradas, KK Oursler, ST Brown, RS Braithwaite, M May, KE Covinsky, MS Roberts, SL Fultz, KJ Bryant and for the VACS Project Team

      Version of Record online: 14 SEP 2009 | DOI: 10.1111/j.1468-1293.2009.00757.x

    8. You have free access to this content
      Discordant responses on starting highly active antiretroviral therapy: suboptimal CD4 increases despite early viral suppression in the UK Collaborative HIV Cohort (UK CHIC) Study (pages 152–160)

      R Gilson, S-L Man, A Copas, A Rider, S Forsyth, T Hill, L Bansi, K Porter, B Gazzard, C Orkin, D Pillay, A Schwenk, M Johnson, P Easterbook, J Walsh, M Fisher, C Leen, J Anderson, CA Sabin and on behalf of the UK Collaborative HIV Cohort Study Group

      Version of Record online: 1 SEP 2009 | DOI: 10.1111/j.1468-1293.2009.00755.x

SEARCH

SEARCH BY CITATION